
3SBio Completes Share Placement to Boost R&D and Global Expansion

I'm PortAI, I can summarize articles.
3SBio Inc. has completed a share placement, raising HK$3,086.84 million to fund R&D and global expansion. The funds will support clinical research on innovative drugs and global infrastructure, with some allocated to working capital. This strategic move aims to enhance market reach and support operations over the next three years. The latest analyst rating for 3SBio stock is Hold with a HK$32.00 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

